Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Tay

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Haematology|November 16, 2020
The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experienceHolly Lee, Jason Tay, Peter Duggan, et al.
Cancers|February 13, 2025
A Prognostic Symptom Model Incorporating Patient-Reported Symptoms for Transplant-Ineligible Patients with Multiple MyelomaAmaris K Balitsky, Rinku Sutradhar, Hsien Seow, et al.
The Annals of Pharmacotherapy|December 8, 2025
A Multicenter, Feasibility Study Exploring Self-Administration of Chemotherapy in the Home Environment: The EASE StudyDarius A Ramrattan, Carole Chambers, Peter Duggan, et al.
Annals of Hematology|July 21, 2021
N-Terminal pro-brain natriuretic peptide (NTproBNP) in patients with symptomatic multiple myeloma: report from a single institutionVictor H Jimenez-Zepeda, Holly Lee, Jason Tay, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2023
Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of CalgaryEllen Lewis, Sylvia McCulloch, Etienne Mahe, et al.
BMJ Open|November 1, 2016
Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot studyJason Tay, David Allan, Sara Beattie, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 8, 2021
Cyclophosphamide, Bortezomib and Methylprednisolone (CyBorMe) for the Treatment of AL Amyloidosis: Initial Experience From a Single CenterVictor H Jimenez-Zepeda, Holly Lee, Nowell Fine, et al.
Transfusion|May 18, 2018
Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysisHilalion Ahn, Jason Tay, Beverley Shea, et al.
Psycho-Oncology|December 13, 2016
Balancing give and take between patients and their spousal caregivers in hematopoietic stem cell transplantationSara Beattie, Sophie Lebel, Danielle Petricone-Westwood, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 28, 2022
Suboptimal response for AL amyloidosis: is it time for early switch? Experience from a single amyloid programRobert Puckrin, Holly Lee, Jason Tay, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Haematology|November 16, 2020
The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experienceHolly Lee, Jason Tay, Peter Duggan, et al.
Cancers|February 13, 2025
A Prognostic Symptom Model Incorporating Patient-Reported Symptoms for Transplant-Ineligible Patients with Multiple MyelomaAmaris K Balitsky, Rinku Sutradhar, Hsien Seow, et al.
The Annals of Pharmacotherapy|December 8, 2025
A Multicenter, Feasibility Study Exploring Self-Administration of Chemotherapy in the Home Environment: The EASE StudyDarius A Ramrattan, Carole Chambers, Peter Duggan, et al.
Annals of Hematology|July 21, 2021
N-Terminal pro-brain natriuretic peptide (NTproBNP) in patients with symptomatic multiple myeloma: report from a single institutionVictor H Jimenez-Zepeda, Holly Lee, Jason Tay, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2023
Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of CalgaryEllen Lewis, Sylvia McCulloch, Etienne Mahe, et al.
BMJ Open|November 1, 2016
Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot studyJason Tay, David Allan, Sara Beattie, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 8, 2021
Cyclophosphamide, Bortezomib and Methylprednisolone (CyBorMe) for the Treatment of AL Amyloidosis: Initial Experience From a Single CenterVictor H Jimenez-Zepeda, Holly Lee, Nowell Fine, et al.
Transfusion|May 18, 2018
Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysisHilalion Ahn, Jason Tay, Beverley Shea, et al.
Psycho-Oncology|December 13, 2016
Balancing give and take between patients and their spousal caregivers in hematopoietic stem cell transplantationSara Beattie, Sophie Lebel, Danielle Petricone-Westwood, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 28, 2022
Suboptimal response for AL amyloidosis: is it time for early switch? Experience from a single amyloid programRobert Puckrin, Holly Lee, Jason Tay, et al.
Pageof 9